Article
Non-invasive prenatal diagnosis for aneuploidy: toward an integral ethical assessment
12 Aug 2011
Abstract excerpt
The great promise of the pending introduction of non-invasive prenatal diagnosis (NIPD) for trisomy 21 (18 and 13) is that it enables one-step, early and safe testing for these abnormalities. The ethical debate so far has been limited to possible drawbacks of routine access to this type of testing: normalization of testing and abortion and adverse effects on autonomous decision-making. We address the ethical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
